Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

COUCH Medcomms

- PMLiVE

How will the new landscape of hepatitis C treatments affect patients?

For this 22 April webinar we bring together a panel of experts in hepatitis C to discuss this important topic, including a healthcare funder, a pharma medical director and an...

Bristol-Myers Squibb (BMS) building

BMS strikes $350m deal to boost its immuno-oncology pipeline

Will collaborate with US biotech Five Prime Therapeutics

EU flag

European Commission sets out HIV/Aids action plan

Says two-year programme proves HIV/Aids remains an EU health policy priority

- PMLiVE

Serviceplan to work with Philipp Lahm

Bayern Munich star signs on as the face of PR firm's latest campaign for AOK

European elections – EFPIA launches social media campaign

Calls for integrated life sciences strategy for the EU

- PMLiVE

McCarthy leaves NHS England

Policy director set for move to the University of Bradford

- PMLiVE

FDA approves new indication for Pfizer/BMS’ Eliquis

Oral anticoagulant gains US approval for deep vein thrombosis use

- PMLiVE

Galapagos divests CRO operations to pursue biotech path

Sells Argenta and BioFocus to Charles River Laboratories for up to €134m

- PMLiVE

Novella Clinical appoints Dr Chris Smyth to head European and Asian operations

He joins the Quintiles company from fellow CRO INC Research

- PMLiVE

Smartphone gamers take one month to decode six months of genetic data

Cancer Research UK details first progress from its new mobile game

- PMLiVE

This month in 1996: Ciba-Geigy and Sandoz merge

The story behind Novartis’ formation resonates today

UK flag

UK gets its own ‘breakthrough’ status for early medicines access

But concerns remain over funding

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links